SCHEMBL4097986

SCHEMBL4097986

COc1cc(C)c(Cl)nn1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
HTT P42858 1/20 0.42
KDM4E B2RXH2 1/20 0.39
NNMT P40261 2/20 0.39
RECQL P46063 1/20 0.36
POLB P06746 1/20 0.34
CYP2A6 P11509 1/20 0.33
CYP1A2 P05177 1/20 0.32
KMT2A Q03164 1/20 0.32
PDE2A O00408 1/20 0.31
MAOB P27338 1/20 0.30
PROKR1 Q8TCW9 1/20 0.30
PDGFRB P09619 1/20 0.30
PDGFRA P16234 1/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14123466 0.79 KDM4E (0.41) ALDH1A1HTTKDM4ENNMTKMT2A
SCHEMBL6823958 0.76 TDP1 (0.52) ALDH1A1HTTKDM4ENNMTPOLB
SCHEMBL29550586 0.75 SIGMAR1 (0.32) HTTRECQLKMT2APDE2ALMNA
SCHEMBL23554573 0.75 SIGMAR1 (0.32) HTTRECQLKMT2APDE2ALMNA
SCHEMBL4278709 0.74 RECQL (0.50) ALDH1A1HTTKDM4ENNMTRECQL
SCHEMBL22833423 0.73 NNMT (0.43) ALDH1A1HTTKDM4ENNMTRECQL
SCHEMBL18248767 0.73 KDM4E (0.39) ALDH1A1HTTKDM4ENNMTRECQL
SCHEMBL17773616 0.72 KDM4E (0.36) ALDH1A1HTTKDM4ENNMTRECQL
SCHEMBL21719496 0.72 KDM4E (0.36) ALDH1A1HTTKDM4EKMT2ALMNA
SCHEMBL15350241 0.71 IL1B (0.36) ALDH1A1KDM4ERECQLCYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9464087-B2 Difluoromethylation of unsaturated compounds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-10-11 US disclosed
US-20150011760-A1 Difluoromethylation Of Unsaturated Compounds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-01-08 US disclosed
US-20090215766-A1 TETRACYCLIC INHIBITORS OF JANUS KINASES INCYTE CORPORATION 2009-08-27 US disclosed
US-20080175794-A1 Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine Analogues NEUROGEN CORPORATION (US) 2008-07-24 US disclosed
US-20080175794-A1 Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine Analogues NEUROGEN CORPORATION (US) 2008-07-24 US disclosed
US-20060106020-A1 Tetracyclic inhibitors of Janus kinases INCYTE CORPORATION 2006-05-18 US disclosed
WO-2005105814-A1 TETRACYCLIC INHIBITORS OF JANUS KINASES INCYTE CORPORATION (US) 2005-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215766-A1 TETRACYCLIC INHIBITORS OF JANUS KINASES JAK1, JAK2, JAK3 ALDH1A1 3857/4885HTT 3366/4885KDM4E 867/4885
US-20150011760-A1 Difluoromethylation Of Unsaturated Compounds ZRANB2, FDPS, NISCH ALDH1A1 1448/4885HTT 4507/4885KDM4E 4329/4885
US-20060106020-A1 Tetracyclic inhibitors of Janus kinases JAK1, JAK2, JAK3 ALDH1A1 3857/4885HTT 3366/4885KDM4E 867/4885
US-20080175794-A1 Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine Analogues PIGS, HRH4, GPR68 ALDH1A1 2392/4885HTT 1123/4885KDM4E 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.